ELLI, ELENA MARIA
ELLI, ELENA MARIA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Circulating endothelial cells and endothelial activation in essential thrombocythemia: Results from CD146(+) immunomagnetic enrichment-flow cytometry and soluble E-selectin detection
2012 Belotti, A; Elli, E; Speranza, T; Lanzi, E; Pioltelli, P; Pogliani, E
A CASE OF ATYPICAL PROLONGED HEMATOLOGIC TOXICITY WITH AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), REVIEW OF LITERATURE AND A PROPOSAL OF MANAGEMENT
2012 Elli, E; Cecchetti, C; Belotti, A; Borin, L; Pogliani, E
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN
2012 Antonioli, E; Guglielmelli, P; Pieri, L; Finazzi, M; Rumi, E; Martinelli, V; Vianelli, N; Luigia Randi, M; Bertozzi, I; De Stefano, V; Za, T; Rossi, E; Ruggeri, M; Elli, E; Cacciola, R; Cacciola, E; Pogliani, E; Rodeghiero, F; Baccarani, M; Passamonti, F; Finazzi, G; Rambaldi, A; Bosi, A; Cazzola, M; Barbui, T; Vannucchi, A
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia
2014 Donadoni, C; Piazza, R; Fontana, D; Parmiani, A; Pirola, A; Redaelli, S; Signore, G; Piazza, V; Malcovati, L; Spinelli, R; Magistroni, V; Gaipa, G; Peronaci, M; Morotti, A; Panuzzo, C; Saglio, G; Elli, E; Usala, E; Kim, D; Rea, D; Zervakis, K; Viniou, N; Symeonidis, A; Becker, H; Boultwood, J; Campiotti, L; Carrabba, M; Bignell, G; Papaemmanuil, E; Campbell, P; Cazzola, M; GAMBACORTI PASSERINI, C
Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis
2014 Elli, E; Belotti, A; Aroldi, A; Parma, M; Pioltelli, P; Pogliani, E
Good outcome for very high risk adult B-cell acute lymphoblastic leukaemia carrying genetic abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if promptly submitted to allogeneic transplantation, after obtaining a good molecular remission
2015 Parma, M; Viganò, C; Fumagalli, M; Colnaghi, F; Colombo, A; Mottadelli, F; Rossi, V; Elli, E; Terruzzi, E; Belotti, A; Cazzaniga, G; Pogliani, E; Pioltelli, P
Neurological symptoms in essential thrombocythemia: Impact of JAK2V617F mutation and response to therapy
2016 Aroldi, A; Cecchetti, C; Colombo, A; Cattaneo, L; Pioltelli, P; Pogliani, E; Elli, E
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib
2018 Bonometti, A; Bagnoli, F; Fanoni, D; Venegoni, L; Corti, L; Bianchi, P; Elli, E; Isimbaldi, G; L'Imperio, V; Nazzaro, G; Passoni, E; Berti, E
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis
2019 Mauri, M; Elli, E; D'Aliberti, D; Crespiatico, I; Nava, M; Massimino, L; Sharma, G; Fontana, D; Redaelli, S; Bombelli, S; Pelucchi, S; Perego, R; Piperno, A; Gambacorti Passerini, C; Piazza, R
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients
2019 Fontana, D; Ramazzotti, D; Aroldi, A; Niro, A; Massimino, L; Rea, D; Stagno, F; Martino, B; Campiotti, L; Caocci, G; Elli, E; Fumagalli, M; Ciceri, F; Piazza, R; GAMBACORTI PASSERINI, C
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors
2019 Andriani, A; Elli, E; Trape, G; Villiva, N; Fianchi, L; Di Veroli, A; Niscola, P; Centra, A; Anaclerico, B; Montanaro, G; Martini, V; Aroldi, A; Carmosino, I; Voso, M; Breccia, M; Montanaro, M; Foa, R; Latagliata, R
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia
2020 Fontana, D; Ramazzotti, D; Aroldi, A; Redaelli, S; Magistroni, V; Pirola, A; Niro, A; Massimino, L; Mastini, C; Brambilla, V; Bombelli, S; Bungaro, S; Morotti, A; Rea, D; Stagno, F; Martino, B; Campiotti, L; Caocci, G; Usala, E; Merli, M; Onida, F; Bregni, M; Elli, E; Fumagalli, M; Ciceri, F; Perego, R; Pagni, F; Mologni, L; Piazza, R; Gambacorti-Passerini, C
Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study
2020 Gemelli, M; Elli, E; Elena, C; Iurlo, A; Intermesoli, T; Maffioli, M; Pungolino, E; Carraro, M; D'Adda, M; Lunghi, F; Anghileri, M; Polverelli, N; Rossi, M; Bacciocchi, M; Bono, E; Bucelli, C; Passamonti, F; Antolini, L; Passerini, C
Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis
2021 Rambaldi, B; Diral, E; Donsante, S; Di Marzo, N; Mottadelli, F; Cardinale, L; Dander, E; Isimbaldi, G; Pioltelli, P; Biondi, A; Riminucci, M; D'Amico, G; Elli, E; Pievani, A; Serafini, M
Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study
2021 Cavalca, F; Renso, R; Zambrotta, G; Gambacorti Passerini, C; Elli, E
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis
2022 Elli, E; Mauri, M; D’Aliberti, D; Crespiatico, I; Fontana, D; Redaelli, S; Pelucchi, S; Manghisi, B; Cavalca, F; Ripamonti, A; Brioschi, F; Palamini, S; Mottadelli, F; Ramazzotti, D; Piperno, A; Gambacorti Passerini, C; Piazza, R
Large-Scale Analysis of SARS-CoV-2 Synonymous Mutations Reveals the Adaptation to the Human Codon Usage During the Virus Evolution
2022 Ramazzotti, D; Angaroni, F; Maspero, D; Mauri, M; D’Aliberti, D; Fontana, D; Antoniotti, M; Elli, E; Graudenzi, A; Piazza, R
Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review
2023 Fontana, D; Elli, E; Pagni, F; Piazza, R
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia
2023 Inzoli, E; Crisa, E; Pugliese, N; Civettini, I; Lanzarone, G; Castelli, A; Martinelli, V; Montelisciani, L; Antolini, L; Gambacorti-Passerini, C; Elli, E
Idiopathic erythrocytosis: a germline disease?
2024 Elli, E; Mauri, M; D’Aliberti, D; Crespiatico, I; Fontana, D; Redaelli, S; Pelucchi, S; Spinelli, S; Manghisi, B; Cavalca, F; Aroldi, A; Ripamonti, A; Ferrari, S; Palamini, S; Mottadelli, F; Massimino, L; Ramazzotti, D; Cazzaniga, G; Piperno, A; Gambacorti-Passerini, C; Piazza, R